Key result
Acute simulated postprandial hyperglycemia doubled circulating malondialdehyde but did not affect acetylcholine-mediated coronary vasodilation or blood flow velocity in cardiac transplant recipients.
Why the study?
Does acute simulated postprandial hyperglycemia impair coronary endothelial function in cardiac transplant recipients without diabetes?
Does acute simulated postprandial hyperglycemia impair coronary endothelial function in cardiac transplant recipients without diabetes?
A single acute episode of hyperglycemia induces systemic oxidative stress but does not acutely impair coronary endothelial NO release or action in cardiac transplant recipients.
Acute hyperglycemia may not impair coronary endothelial function in transplant recipients despite oxidative stress; leaves open chronic effects on graft vasculopathy.
Patients with diabetes mellitus exhibit postprandial hyperglycemia, systemic oxidative stress, impaired endothelium-dependent, nitric oxide (NO)-mediated coronary artery dilatation, and an increased incidence of coronary events. Whether hyperglycemia causally mediates these associations is unknown. To test the hypothesis that postprandial hyperglycemia acutely impairs coronary endothelial function in humans, we compared the ability of the endothelium-dependent vasodilator acetylcholine to increase conduit coronary diameter (the macrovascular response) and coronary blood flow velocity (the microvascular response) in 12 cardiac transplant recipients without diabetes before and after blood glucose was raised from 6.7 +/- 1.3 mmol/l (121 +/- 24 mg/dl) to 17.8 +/- 1.5 mmol/l (321 +/- 27 mg/dl) for 1 h. Hyperglycemia acutely doubled circulating levels of the oxidation product malondialdehyde, indicating systemic oxidative stress, but did not affect the ability of acetylcholine to dilate conduit coronary segments or accelerate coronary blood flow. We conclude that the oxidative stress associated with a single acute episode of hyperglycemia affects neither acetylcholine-mediated coronary endothelial NO release nor the subsequent bioavailability, metabolism, or action of NO within the coronary circulation of cardiac transplant recipients. These observations imply that the relationship among hyperglycemia, oxidative stress, and coronary endothelial dysfunction is presumably mediated by mechanisms operating over longer periods of time.
No takes yet. Share an insight, caveat, or question.
McNulty et al. (2007) studied cardiac transplant recipients without diabetes (n=12). Simulated postprandial hyperglycemia vs. Baseline (6.7 +/- 1.3 mmol/l) was evaluated on Ability of acetylcholine to increase conduit coronary diameter and coronary blood flow velocity. Acute simulated postprandial hyperglycemia doubled circulating malondialdehyde but did not affect acetylcholine-mediated coronary vasodilation or blood flow velocity in cardiac transplant recipients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: